Reports of Biochemistry and Molecular Biology
rbmb.net
Basic Sciences
http://rbmb.net
1
admin
2322-3480
2322-3480
10.61186/rbmb
en
jalali
1401
11
1
gregorian
2023
2
1
11
4
online
1
fulltext
en
Transforming Growth Factor Β as a Marker of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Virus Infection
بیوشیمی
Biochemistry
مقالات اصلی
Original Article
<div style="text-align: justify;"><span style="text-justify:kashida"><span style="text-kashida:0%"><span style="line-height:normal"><span style="tab-stops:396.55pt"><b><i><span style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="letter-spacing:-.3pt">Background:</span></span></span></i></b><b><i> </i></b><span style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="letter-spacing:-.3pt">The Transforming Growth Factor-beta (TGF-β) is one of the main growth factors associated with fibrosis or cirrhosis progression in the liver, but its role in hepatocarcinogenesis is controversial.<b><i> </i></b>To highlight the role of Transforming Growth Factor β as a marker of Hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus (HCV) infection.</span></span></span></span></span></span></span><br>
<br>
<span style="text-justify:kashida"><span style="text-kashida:0%"><span style="line-height:normal"><span style="tab-stops:396.55pt"><b><i><span style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="letter-spacing:-.3pt">Methods:</span></span></span></i></b> <span style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="letter-spacing:-.3pt">Ninety subjects were enrolled in this study, classified into three groups: Group I (chronic HCV group) included 30 patients with chronic HCV infection; Group II (HCC group) include 30 patients having HCC and chronic HCV infection and Group III consisted of 30 age and sex-matched healthy controls. TGF-β was evaluated in all the enrollees and its levels were correlated to liver function and other clinical parameters.</span></span></span></span></span></span></span><br>
<br>
<span style="text-justify:kashida"><span style="text-kashida:0%"><span style="line-height:normal"><span style="tab-stops:396.55pt"><b><i><span style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="letter-spacing:-.3pt">Results:</span></span></span></i></b> <span style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="letter-spacing:-.3pt">TGF-β was found significantly higher in HCC group than in control and chronic HCV (P <0.001). In addition, it was correlated with biochemical and clinical parameters of cancer.</span></span></span><br>
<span lang="EN-ID" style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="letter-spacing:-.3pt"></span></span></span></span></span></span></span><br>
<span style="text-justify:kashida"><span style="text-kashida:0%"><span style="line-height:normal"><span style="tab-stops:396.55pt"><b><i><span style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="letter-spacing:-.3pt">Conclusions:</span></span></span></i></b> <span style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""><span style="letter-spacing:-.3pt">Patients with HCC showed increased level of TGF-β compared to chronic HCV infection patients and controls.</span></span></span></span></span></span></span></div>
Chronic HCV, Liver cirrhosis, Transforming Growth Factor β.
702
709
http://rbmb.net/browse.php?a_code=A-10-1039-1&slc_lang=en&sid=1
Assem
Abdeen Radwan
eltabeeb84@gmail.com.
100319475328460014244
100319475328460014244
Yes
Department of Internal Medicine, Faculty of Medicine, Aswan University, Egypt.
Nour El-Dean
Abd-Elazeem Hefney
100319475328460014245
100319475328460014245
No
Department of Internal Medicine, Faculty of Medicine, Assuit University, Egypt.
Emad Farah
Mohammed Kholef
100319475328460014246
100319475328460014246
No
Department of Clinical Pathology, Faculty of Medicine, Aswan University, Egypt.
Abdallah
Elebidi
100319475328460014247
100319475328460014247
No
Department of Medical Biochemistry, Faculty of Medicine, Aswan University, Egypt.
Hala
Mahmoud
100319475328460014248
100319475328460014248
No
Department of Internal Medicine, Faculty of Medicine, Aswan University, Egypt.